Austin Smith |
XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500
Healthcare isn’t going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of…